Ameritas Investment Partners’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159K | Hold |
9,349
| – | – | 0.01% | 1449 |
|
|
2025
Q1 | $183K | Buy |
9,349
+1,350
| +17% | +$26.4K | 0.01% | 1317 |
|
|
2024
Q4 | $198K | Buy |
7,999
+496
| +7% | +$12.3K | 0.01% | 1326 |
|
|
2024
Q3 | $184K | Hold |
7,503
| – | – | 0.01% | 1379 |
|
|
2024
Q2 | $176K | Hold |
7,503
| – | – | 0.01% | 1362 |
|
|
2024
Q1 | $248K | Hold |
7,503
| – | – | 0.01% | 1145 |
|
|
2023
Q4 | $204K | Buy |
7,503
+713
| +11% | +$19.4K | 0.01% | 1254 |
|
|
2023
Q3 | $163K | Buy |
6,790
+1,147
| +20% | +$27.6K | 0.01% | 1315 |
|
|
2023
Q2 | $180K | Buy |
5,643
+660
| +13% | +$21.1K | 0.01% | 1196 |
|
|
2023
Q1 | $153K | Hold |
4,983
| – | – | 0.01% | 1260 |
|
|
2022
Q4 | $221K | Hold |
4,983
| – | – | 0.01% | 1081 |
|
|
2022
Q3 | $237K | Buy |
4,983
+216
| +5% | +$10.3K | 0.01% | 980 |
|
|
2022
Q2 | $184K | Buy |
4,767
+811
| +21% | +$31.3K | 0.01% | 1114 |
|
|
2022
Q1 | $227K | Hold |
3,956
| – | – | 0.01% | 1110 |
|
|
2021
Q4 | $315K | Buy |
3,956
+135
| +4% | +$10.7K | 0.01% | 954 |
|
|
2021
Q3 | $332K | Buy |
3,821
+137
| +4% | +$11.9K | 0.01% | 908 |
|
|
2021
Q2 | $474K | Buy |
3,684
+342
| +10% | +$44K | 0.02% | 810 |
|
|
2021
Q1 | $267K | Hold |
3,342
| – | – | 0.01% | 1033 |
|
|
2020
Q4 | $273K | Buy |
3,342
+331
| +11% | +$27K | 0.01% | 976 |
|
|
2020
Q3 | $74K | Buy |
3,011
+1,961
| +187% | +$48.2K | ﹤0.01% | 1610 |
|
|
2020
Q2 | $29K | Hold |
1,050
| – | – | ﹤0.01% | 2149 |
|
|
2020
Q1 | $19K | Buy |
+1,050
| New | +$19K | ﹤0.01% | 2202 |
|